Precursor T-cell Acute Lymphoblastic Leukemia
📧 Sign up to get email alerts when something new happens for Precursor T-cell Acute Lymphoblastic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-10-13Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Daratumumab in Pediatric and Young Adult Participants Greater Than or Equal to (>=)1 and Less Than or Equal to (<=) 30 Years of Age With Relapsed/Refractory Precursor B-cell or T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma [Phase 2]
Phase 2 study evaluating daratumumab for relapsed/refractory precursor B-cell or T-cell acute lymphoblastic leukemia and lymphoblastic lymph…